Contributions of leukocytes to tumor invasion and metastasis: The "piggy-back" hypothesis

Cancer Epidemiology

Volumn 34, Issue 1, 2010, Pages 3-6

  Man, Yan gao ^a   Harley, Russell ^a   Mason, Jeffrey ^a   Gardner, William A ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; PROTEINASE INHIBITOR;

ARTICLE; BASAL CELL; BREAST LESION; CANCER CELL; CANCER INVASION; CELL FUNCTION; CELL FUSION; CELL INFILTRATION; CELL PROLIFERATION; CLINICAL TRIAL; HUMAN; HYPERPLASIA; LEUKOCYTE; LYMPH VESSEL; LYMPHOCYTIC INFILTRATION; MEMBRANE STRUCTURE; METASTASIS; MYOEPITHELIUM; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR CELL;

EID: 76449088998     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2009.11.005     Document Type: Note

References (45)

1. Clarke R., Brunner N., and Katzenellenbogen B.S. Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo. Proc Natl Acad Sci USA 86 (1989) 3649-3653
2. Beckmann M.W., Niederacher D., Schnurch H.G., Gusterson B.A., and Bender H.G. Multistep carcinogenesis of breast cancer and tumor heterogeneity. J Mol Med 75 (1997) 429-439
3. Goldfarb R.H., and Liotta L.A. Proteolytic enzymes in cancer invasion and metastasis. Semin Thromb Hemost 12 (1986) 294-307
4. Duffy M.J., Maguire T.M., Hill A., McDermott E., and O'Higgins N. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2 (2000) 252-257
5. Millis R.R., and Thynne G.S. In situ intraduct carcinoma of the breast: a long term follow-up study. Br J Surg 62 (1975) 957-962
6. Goeman L., Joniau S., Ponette D., Van der Aa F., Roskams T., Oyen R., et al. Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer. Prostate Cancer Prostatic Dis 6 (2003) 305-310
7. Page D.L., Duppont W.D., Rogers L.W., and Landenberger M. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer 49 (1982) 751-758
8. Coussens L.M., Fingleton B., and Matrisian L.M. Matrix metalloproteinase inhibitors and cancer: trial and tribulations. Science 295 5564 (2002) 2387-2392
9. Matrisian L.M., Sledge Jr. G.W., and Mohla S. Exacellular proteolysis and cancer: meeting summary and future directions. Cancer Res 63 (2003) 6105-6109
10. Kasahara Y., and Tsukada Y. New insights and future advances in cancer diagnostics: Limitations of conventional tumor markers. In: Nakarnura R.M., Grody W.W., Wu J.T., and Nagle R.B. (Eds). Cancer Diagnostics: Current and Future Trends (2004), Humanna Press, Totowa, NJ 15-26
11. Warnberg F., Nordgren H., Bergkvist L., and Hulmberg L. Tumor markers in breast carcinomas correlate with grade rather than with invasiveness. Br J Cancer 85 (2001) 869-874
12. Leonard G.D., and Swain S.M. Ductal carcinoma in situ, complexities and challenges. J Nat Cancer Inst 96 (2004) 906-920
13. Zaugg K., and Bodis S. Is there role for molecular prognostic factors in the clinical management of ductal carcinoma in situ (DCIS) of the breast?. Radiother Oncol 55 (2000) 95-99
14. Gottlieb C., Raiu U., and Greenwald K.A. Myoepithelial cells in the differential diagnosis of complex benign and malignant breast lesions:an immunohistochemical study. Mod Pathol 3 (1990) 35-140
15. Guelstein V.I., Tehypysheva T.A., Ermilova V.D., and Liubimov A.V. Myoepithelial and basement membrane antigens in benign and malignant human breast tumors. In J Cancer 53 (1993) 269-277
16. Zhang R., Man Y.G., Vang R.S., Saenger J.S., Barner R., Wheeler D., et al. A subset of morphologically distinct mammary myoepithelial cells lacks corresponding immunophenotypic markers. Breast Cancer Res 5 (2003) R151-R156
17. Man Y.G., Tai L., Barner R., Vang R., Saenger J.S., Shekitka K.M., et al. Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion. Breast Cancer Res 5 (2003) R231-R241
18. Man Y.G., and Sang Q.X.A. The significance of focal myoepitehlial cell layer disruptions in breast tumor invasion: a paradigm shift from the "protease-centered" hypothesis. Exp Cell Res 301 (2004) 103-118
19. Yousefi M., Mattu R., Gao C., and Man Y.G. Mammary ducts with and without focal myoepithelial cell layer disruptions show a different frequency of white blood cell infiltration and growth pattern: implications for tumor progression and invasion. Appl Immunohistochem Mol Morphol 13 (2005) 30-37
20. Man Y.G., Shen T., Weisz J., Berg P.E., Schwartz A.M., Mulshine J.L., et al. A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion. Cancer Detect Prev 29 (2005) 323-331
21. Man Y.G., Zhao C.Q., and Wang J. Breast tumor cell clusters and their budding derivatives show different immunohistochemical profiles during stromal invasion: implications for hormonal and drug therapies. Cancer Ther 4 (2006) 193-204
22. Man Y.G., and Nieburgs H.E. A subset of cell clusters with malignant features in morphologically normal and hyperplastic breast tissues. Cancer Detect Prev 30 3 (2006) 239-247
23. Man Y.G., Zhao C.Q., Wang J., and Chen X.L. A subset of prostate basal cells lacks corresponding phenotypic markers. Pathol Res Pract 202 9 (2006) 651-662
24. Xu Z.L., Wang W., Deng C.X., and Man Y.G. Aberrant p63 and WT-1 expression in myoepithelial cells of pregnancy-associated breast cancer: implications for tumor aggressiveness and invasiveness. Int J Biol Sci 5 1 (2009) 82-96
25. Liu A.J., Wei L.X., Gardner W.A., and Man Y.G. Correlated alterations in prostate basal cell layer and basement membrane. Int J Biol Sci 5 (2009) 276-285
26. Man Y.G., Zhang Y., Shen T., Vinh T.N., Zeng X., Tauler J., et al. cDNA expression profiling identifies elevated expressions of tumor progression and invasion-related genes in cell clusters of in situ breast tumors. Breast Cancer Res Treat 89 (2005) 199-208
27. Zhang X.C., Hashemi S.S., Yousefi M., Gao C.L., Sheng J., Mason J., et al. Atypical expression of c-erbB2 in cell clusters overlying focally disrupted breast myoepithelial cell layers: a potential sign for increasing cell motility and invasion. Int J Biol Sci 4 (2008) 259-269
28. Zhang X.C., Hashemi S.S., Yousefi M., Gao C.L., Sheng J., Mason J., et al. Atypical expression of e-cadherin in cell clusters overlying focally disrupted mammary myoepithelial cell layers: implications for tumor cell motility and invasion. Pathol Res Pract 205 (2009) 375-385
29. Man Y.G., Shen T., Zhao Y.G., and Sang Q.X. Focal prostate basal cell layer disruptions and leukocyte infiltration are correlated events: a potential mechanism for basal cell layer disruptions and tumor invasion. Cancer Detect Prev 29 (2005) 161-169
30. Man Y.G. Focal degeneration of aged or injured myoepithelial cells and the resultant auto-immunoreactions are trigger factors for breast tumor invasion. Med Hypotheses 69 6 (2007) 1340-1357
31. Man Y.G., and Gardner W.A. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion. Med Hypotheses 70 (2008) 387-408
32. Man Y.G., and Gardner W.A. Bad seeds produce bad crops: a single step-process of prostate carcinogenesis and progression. Int J Biol Sci 4 (2008) 246-258
33. Man Y.G. Bad seeds produce bad crops: a single step-process of breast carcinogenesis and progression. Biosci Hypotheses 1 (2008) 147-155
34. Pawelek J.M., and Chakraborty A.K. The cancer cell-leukocyte fusion theory of metastasis. Adv Cancer Res 101 (2008) 397-444
35. Pawelek J.M., and Chakraborty A.K. Fusion of tumor cells with bone marrow-derived cells: a unifying explanation for metastasis. Nat Rev Cancer 8 5 (2008) 377-386
36. Pawelek J.M. Tumor cell fusion as a source of myeloid traits in cancer. Lancet Oncol 6 12 (2005) 988-993
37. Pawelek J.M., Chakraborty A., Lazova R., Yilmaz Y., Cooper D., Brash D., and Handerson T. Co-opting macrophage traits in cancer progression: a consequence of tumor cell fusion?. In: Dittmar T., Zaenker K.S., and Schmidt (Eds). Infection and Inflammation: Impacts on Oncogenesis vol. 13 (2006), Karger, Basel 138-155 Contrib Microbiol
38. Smith C.J., and Gardner Jr. W.A. Inflammation-proliferation: possible relationships in the prostate. Prog Clin Biol Res 239 (1987) 317-325
39. Gannot G., Gannot I., Vered H., Buchner A., and Keisari Y. Increase in immune cell infiltration with progression of oral epithelium from hyperkeratiosis to dysplasia and carcinoma. Br J Cancer 86 (2002) 1444-1448
40. MacLennan G.T., Eisenberg R., Fleshman R.L., Taylor J.M., Fu P., Resnick M.I., et al. The influence of chronic inflammation in prostatic carcinogenesis: a 5-year follow-up study. J Urol 176 (2006) 1012-1016
41. O'Brien J., and Schedin P. Macrophages in breast cancer: do involution macrophages account for the poor prognosis of pregnancy-associated breast cancer?. J Mammary Gland Biol Neoplasia 14 2 (2009) 145-157
42. Mathelin C., Annane K., Treisser A., Chenard M.P., Tomasetto C., Bellocq J.P., et al. Pregnancy and post-partum breast cancer: a prospective study. Anticancer Res 28 4C (2008) 2447-2452
43. Rodriguez A.O., Chew H., Cress R., Xing G., McElvy S., Danielsen B., et al. Evidence of poorer survival in pregnancy-associated breast cancer. Obstet Gynecol 112 1 (2008) 71-78
44. Bonnier P., Romain S., Dilhuydy J.M., Bonichon F., Julien J.P., Charpin C., et al. Influence of pregnancy on the outcome of breast cancer: a case-control study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group. Int J Cancer 72 (1997) 720-727
45. Peek Jr. R.M., Mohla S., and DuBois R.N. Inflammation in the genesis and perpetuation of cancer: summary and recommendations from a national cancer institute-sponsored meeting. Cancer Res 65 (2005) 8583-8586